Active ingredient
Registrations named Rifampicin
Rifampicin is an active ingredient, not a brand name. 30 registrations in the DRAP register carry it in the product name, and the price index attributes them to 1 manufacturer — these are generic products, not one company's range.
- Registrations
- 30
- Manufacturers
- 1
- Dosage forms
- Capsule · Tablet · Syrup
- Approved price range
- Rs 38.59 – Rs 382.14
Registrations
| Registered name | Reg. No. | Strength | Form | Manufacturer | Price from |
|---|---|---|---|---|---|
| RIFAMPICIN 150MG CAP | 009927 | 150MG | Capsule | — | — |
| RIFAMPICIN 150MG TAB | 009892 | 150MG | Tablet | — | — |
| RIFAMPICIN 20MG SYP | 009929 | 20MG | Syrup | — | — |
| RIFAMPICIN 300MG CAP | 009928 | 300MG | Capsule | — | — |
| RIFAMPICIN 300MG CAPSULE | 005764 | 300MG | Capsule | — | — |
| Rifampicin 300mg Capsules | 022972 | 300mg | Capsule | — | — |
| RIFAMPICIN 300MG TAB | 009265 | 300MG | Tablet | — | — |
| RIFAMPICIN 300MG TAB | 009893 | 300MG | Tablet | — | — |
| RIFAMPICIN 450MG CAP | 005422 | 450MG | Capsule | — | — |
| RIFAMPICIN 450MG CAP | 007611 | 450MG | Capsule | — | — |
| RIFAMPICIN 450MG CAPSULE | 005765 | 450MG | Capsule | — | — |
| RIFAMPICIN 450MG TAB | 009779 | 450MG | Tablet | — | — |
| RIFAMPICIN 450MG TAB | 009917 | 450MG | Tablet | — | — |
| RIFAMPICIN 600MG TAB | 009780 | 600MG | Tablet | — | — |
| RIFAMPICIN CAP | 005164 | — | Capsule | — | — |
| RIFAMPICIN CAPSULE | 003647 | — | Capsule | — | — |
| RIFAMPICIN CAPSULE 300 MG | 000032-EX | 300 MG | Capsule | — | — |
| Rifampicin Capsule 300mg | 009783 | 300mg | Capsule | Zafa Pharmaceutical Laboratories (Pvt) Ltd. | Rs 65.82 |
| RIFAMPICIN CAPSULES | 018263 | — | Capsule | — | — |
| Rifampicin Capsules 150mg | 009782 | 150mg | Capsule | Zafa Pharmaceutical Laboratories (Pvt) Ltd. | Rs 38.59 |
| RIFAMPICIN CAPSULES 150MG | 005324 | 150MG | Capsule | — | — |
| RIFAMPICIN CAPSULES 150MG | 008467 | 150MG | Capsule | — | — |
| RIFAMPICIN CAPSULES 150MG | 008771 | 150MG | Capsule | — | — |
| RIFAMPICIN CAPSULES 300MG | 005325 | 300MG | Capsule | — | — |
| RIFAMPICIN CAPSULES 300MG | 008468 | 300MG | Capsule | — | — |
| RIFAMPICIN CAPSULES 300MG | 008772 | 300MG | Capsule | — | — |
| Rifampicin Capsules 400mg | 009784 | 400mg | Capsule | Zafa Pharmaceutical Laboratories (Pvt) Ltd. | Rs 101.83 |
| RIFAMPICIN CAPSULES 450MG | 005326 | 450MG | Capsule | — | — |
| Rifampicin Syrup | 009786 | — | Syrup | Zafa Pharmaceutical Laboratories (Pvt) Ltd. | Rs 64.46 |
| Rifampicin Tablets | 022949 | — | Tablet | — | — |
Why this is not described as a brand
The DRAP register has no separate brand column, so an ingredient name and a trade name look identical in the data. This group is an ingredient: the products below are made by different companies under their own trade names, and no single company owns the word.
How these are grouped
These registrations are grouped by the words in their registered name. Strength, pack size, dosage form and trailing variant words such as Forte, Extra, CF, DS and XR are removed before grouping, so Panadol Tablet, Panadol CF Tablet and Panadol Extra Tablet count as one group. Names that only share a first word but mean different things — for example two companies' unrelated products — can still land together; the registered name of every row is shown so the grouping is checkable.
Source: the bundled DRAP registered-products index and the DRAP price index. Prices are regulatory listings, not pharmacy stock or a retail quote.